Paul K. Audhya Kal Vista Pharmaceuticals, Inc. (KALV) insider trading activity

Paul K. Audhya is CHIEF MEDICAL OFFICER of KalVista Pharmaceuticals, Inc.. Currently has a direct ownership of 97,012 shares of KALV, which is worth approximately $811,020. The most recent transaction as insider was on Nov 26, 2024, when has been sold 2,187 shares (Common Stock) at a price of $9.87 per share, resulting in proceeds of $21,585. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 97K

15.84% 3M change

165.29% 12M change

Total Value Held $811,020

Paul K. Audhya Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 26 2024	SELL Open market or private sale	$21,585 $9.87 p/Share	2,187 Reduced 2.2%	97,012 Common Stock
Nov 22 2024	BUY Exercise of conversion of derivative security	-	5,000 Added 4.8%	99,199 Common Stock
Nov 18 2024	SELL Open market or private sale	$74,793 $9.26 p/Share	8,077 Reduced 7.9%	94,199 Common Stock
Nov 17 2024	BUY Exercise of conversion of derivative security	-	18,531 Added 15.34%	102,276 Common Stock
Aug 23 2024	SELL Open market or private sale	$26,474 $12.4 p/Share	2,135 Reduced 2.49%	83,745 Common Stock
Aug 22 2024	BUY Exercise of conversion of derivative security	-	5,000 Added 5.5%	85,880 Common Stock
Aug 19 2024	SELL Open market or private sale	$95,755 $12.01 p/Share	7,973 Reduced 8.97%	80,880 Common Stock
Aug 17 2024	BUY Exercise of conversion of derivative security	-	18,528 Added 17.25%	88,853 Common Stock
May 20 2024	SELL Open market or private sale	$154,938 $11.76 p/Share	13,175 Reduced 15.78%	70,325 Common Stock
May 17 2024	BUY Exercise of conversion of derivative security	-	30,614 Added 26.83%	83,500 Common Stock
Feb 20 2024	SELL Open market or private sale	$201,845 $14.12 p/Share	14,295 Reduced 21.28%	52,886 Common Stock
Feb 17 2024	BUY Exercise of conversion of derivative security	-	30,613 Added 31.3%	67,181 Common Stock
Nov 20 2023	SELL Open market or private sale	$65,716 $8.23 p/Share	7,985 Reduced 17.92%	36,568 Common Stock
Nov 17 2023	BUY Exercise of conversion of derivative security	-	18,530 Added 29.37%	44,553 Common Stock
Aug 18 2023	SELL Open market or private sale	$86,054 $10.73 p/Share	8,020 Reduced 23.56%	26,023 Common Stock
Aug 17 2023	BUY Exercise of conversion of derivative security	-	18,529 Added 35.24%	34,043 Common Stock
May 18 2023	SELL Open market or private sale	$28,189 $10.14 p/Share	2,780 Reduced 17.6%	13,014 Common Stock
May 17 2023	BUY Exercise of conversion of derivative security	-	6,447 Added 28.99%	15,794 Common Stock
Feb 17 2023	SELL Open market or private sale	$26,135 $7.66 p/Share	3,412 Reduced 26.74%	9,347 Common Stock
Feb 17 2023	BUY Exercise of conversion of derivative security	-	6,446 Added 50.52%	6,313 Common Stock
Nov 18 2022	SELL Open market or private sale	$3,927 $5.44 p/Share	722 Reduced 10.83%	5,946 Common Stock
Nov 17 2022	BUY Exercise of conversion of derivative security	-	2,419 Added 26.62%	6,668 Common Stock
Aug 17 2022	SELL Open market or private sale	$10,846 $14.96 p/Share	725 Reduced 29.98%	1,693 Common Stock
Aug 17 2022	BUY Exercise of conversion of derivative security	-	2,418 Added 50.0%	2,418 Common Stock

PKA

Paul K. Audhya

CHIEF MEDICAL OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KALV shares.

Notify only if

Value

Insider Trading

Get notified when an Kal Vista Pharmaceuticals, Inc. insider buys or sells KALV shares.

Notify only if

Operation

Value

Type

News

Receive news related to KalVista Pharmaceuticals, Inc.

Track Activities on KALV

Account